StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Goldman Sachs Double Upgrades Merck (MRK) to Conviction Buy
April 23, 2018 5:22 AM
Goldman Sachs upgraded Merck (NYSE: MRK) from Neutral to Conviction Buy with a price target of $73.00 (from $63.00).Analyst Jami ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Hot Upgrades
Upgrades
Next Articles
Merck (MRK) Reports EMA Validation of Type II Variation for KEYTRUDA (pembrolizumab) in Combination with Pemetrexed (ALIMTA) and Platinum Chemotherapy
April 23, 2018 4:35 PM
UPDATE: Merck (MRK) PT Raised to $67 at Cowen
April 20, 2018 6:21 AM
Merck (MRK) PT Raised to $74 at JPMorgan
April 20, 2018 4:42 AM